Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05758-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Jing Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian Province, China. Hauptthemen laut MEDLINE: Fanconi Anemia Complementation Group N Protein, Breast Neoplasms, Germ-Line Mutation, Age of Onset. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fuiian Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
Limited data are available regarding the partner and localizer of BRCA2 ( PALB2 ) in Chinese patients with early breast cancer. This study aimed to assess the spectrum and characteristics of germline PALB2 pathogenic variants in this population.
Methods
Peripheral blood samples were collected from 1556 patients diagnosed with BRCA1/2 -negative early-onset breast cancer . All coding regions and exon‒intron boundaries of the PALB2 genes were screened through next-generation sequencing.
Results
The prevalence of PALB2 pathogenic variants was approximately 0.77% in the cohort. Eleven PALB2 pathogenic variants were identified in twelve participants, including five frameshift mutations and six nonsense mutations. All other variants were detected once, except for PALB2 c.1056_1057del (detected twice). Two PALB2 carriers (2/12, 16.7%) have documented family history of breast cancer and/or ovarian cancer. Patients with a positive family history exhibited a threefold higher possibility of being identified as PALB2 carriers than those without a family history (2% vs. 0.69%), although the difference was not statistically significant ( p = 0.178). Compared to non-carriers, PALB2 carriers has a tendency to appear in younger age (≤ 30 years) (25% vs 14.4%), human epidermal growth factor receptor-2 (HER2)-negative status (83.3% vs. 70.2%), and diagnosed with invasive micropapillary carcinoma (16.7% vs 3.1%).
Conclusion
The prevalence of the germline PALB2 pathogenic variants was approximately 0.77% in Chinese patients with BRCA1/2 -negative early-onset breast cancer. Our findings is crucial for understanding population-specific genetic risks and offering insights that can enhance genetic counseling and genetic testing strategies in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian Province, China.
- Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian Province, China.
- Breast Cancer Institute, Fujian Medical University, Fuzhou, 350001, Fujian Province, China.
- Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian Province, China. chuanwang1968@outlook.com.
- Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian Province, China. chuanwang1968@outlook.com.
- Breast Cancer Institute, Fujian Medical University, Fuzhou, 350001, Fujian Province, China. chuanwang1968@outlook.com.
Förderung
- Natural Science Foundation of Fuiian Province
Zitieren
APA
Li, J., He, P., Cai, Q., Chen, L., Wang, Y., Cai, W., Qiu, Y., Liu, S., Guo, W., Chen, M., Lin, Y., Wang, C., & Fu, F. (2024). Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05758-7
Vancouver
Li J, He P, Cai Q, Chen L, Wang Y, Cai W, et al. Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05758-7
BibTeX
@article{Li2024,
author = {Li, Jing and He, Peng and Cai, Qindong and Chen, Lili and Wang, Yali and Cai, Weifeng and Qiu, Yibin and Liu, Shunyi and Guo, Wenhui and Chen, Minyan and Lin, Yuxiang and Wang, Chuan and Fu, Fangmeng},
title = {Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05758-7}
}
EUVIMED